TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26756766

Group type: EXPERIMENTAL
Intervention: Preoperative supervised exercise for 6 weeks
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 124
Study: 23980693

Group type: EXPERIMENTAL
Intervention: Daily interruption of sedatives (stopped daily and restarted when COMFORT-behavior score ≥17)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Daily interruption of sedatives
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 30
Study: 21812937

Group type: EXPERIMENTAL
Intervention: Refined theory‐based interactive postpartum sexual health education program (IPSHEP)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Interactive, self‐help pamphlet
Number of subjects: 250

Group type: COMPARATOR
Intervention: Routine education (10-15 minute educational talk and sexual health pamphlet)
Number of subjects: 250
Study: 20078813

Group type: EXPERIMENTAL
Intervention: BIS-guided anesthesia
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard practice (SP)
Number of subjects: 50
Study: 18029971

Group type: EXPERIMENTAL
Intervention: Chemoimmunotherapy (5-FU, adriamycin, and poly A:U)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Chemotherapy (5-FU and adriamycin)
Number of subjects: 292
Study: 16294263

Group type: EXPERIMENTAL
Intervention: Risedronate 2.5 or 5 mg daily for up to 3 years
Number of subjects: 3979

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3979
Study: 12131600

Group type: EXPERIMENTAL
Intervention: Venlafaxine (maximum of 150 mg/day)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 28
Study: 11696473

Group type: EXPERIMENTAL
Intervention: CHF patients
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 38
Study: 9136270

Group type: EXPERIMENTAL
Intervention: Object-centered (OC) task
Number of subjects: 12

Group type: COMPARATOR
Intervention: Trajectory-centered (TC) task
Number of subjects: 12
Study: 8052812

Group type: EXPERIMENTAL
Intervention: Fosfomycin/metronidazole
Number of subjects: 488

Group type: COMPARATOR
Intervention: Doxycycline/metronidazole
Number of subjects: 488
Study: 2947149

Group type: EXPERIMENTAL
Intervention: Trimetazidine (20 mg, three tablets daily for two weeks)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo (three tablets daily for two weeks)
Number of subjects: 54
Study: 29482596

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Combination of Haloperidol and Ketamine
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 27232884

Group type: EXPERIMENTAL
Intervention: Cediranib plus gefitinib
Number of subjects: 38

Group type: COMPARATOR
Intervention: Cediranib plus placebo
Number of subjects: 38
Study: 26230563

Group type: EXPERIMENTAL
Intervention: Training program in Depressive disorders integrated with Mindful Practice
Number of subjects: 56
Study: 23997107

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Passive smokers
Number of subjects: 49

Group type: COMPARATOR
Intervention: Never smokers
Number of subjects: 49

Group type: COMPARATOR
Intervention: Former smokers
Number of subjects: 49
Study: 20371737

Group type: EXPERIMENTAL
Intervention: Fesoterodine 8 mg
Number of subjects: 16
Study: 18509576

Group type: EXPERIMENTAL
Intervention: Normocapnic hyperpnoea training
Number of subjects: 14
Study: 17154780

Group type: EXPERIMENTAL
Intervention: 6-cm-diameter disk at a distance of 18 cm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10-cm disk at 50 cm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel physical size object
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Familiar physical size object
Number of subjects: 0
Study: 12662365

Group type: EXPERIMENTAL
Intervention: Advice to reduce dietary fat only
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Advice to reduce dietary fat and sugar
Number of subjects: 25
Study: 10905596

Group type: EXPERIMENTAL
Intervention: Combination therapy (3 MU/thrice weekly of alpha-IFN and 1000-1200 mg/daily of ribavirin)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Alpha-IFN alone (3 MU/thrice weekly)
Number of subjects: 100
Study: 8935140

Group type: EXPERIMENTAL
Intervention: Lactulose
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Senna
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Codanthrusate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination of stimulant and softening laxatives
Number of subjects: 30
Study: 1408620

Group type: EXPERIMENTAL
Intervention: High contextual interference (random practice)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Blocked practice (low interference)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Serial practice
Number of subjects: 52

Group type: COMPARATOR
Intervention: Serial with high interference practice
Number of subjects: 52
Study: 31899111

Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 13

Group type: COMPARATOR
Intervention: No Kinesio Taping (No KT)
Number of subjects: 13
Study: 29293367

Group type: EXPERIMENTAL
Intervention: Standard subcutaneous basal‐bolus insulin and blinded CGM (group 1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Insulin pump and blinded CGM (group 2)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Insulin pump and nonblinded CGM (group 3)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: All treatment groups (CGM)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Group 3 (insulin pump and nonblinded CGM)
Number of subjects: 16
Study: 27573531

Group type: EXPERIMENTAL
Intervention: Video clips of patients describing their colposcopy
Number of subjects: 88

Group type: COMPARATOR
Intervention: Clinician describing the procedure
Number of subjects: 88
Study: 25903251

Group type: EXPERIMENTAL
Intervention: Obesity risk feedback
Number of subjects: 147

Group type: COMPARATOR
Intervention: No obesity risk feedback (Control)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Choosing fewer unhealthful foods
Number of subjects: 147
Study: 22990758

Group type: EXPERIMENTAL
Intervention: Paced breathing twice a day (6 breaths/minute for 15 minutes)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Paced breathing once a day (6 breaths/minute for 15 minutes)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Usual breathing (14 breaths/minute for 10 minutes/day)
Number of subjects: 92
Study: 21071943

Group type: EXPERIMENTAL
Intervention: Caregiver intervention
Number of subjects: 158

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 158
Study: 18656295

Group type: EXPERIMENTAL
Intervention: G-Bond (GC)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Optibond FL (Kerr)
Number of subjects: 52
Study: 16647408

Group type: EXPERIMENTAL
Intervention: Mixing insulin glargine (IG) with a rapid‐acting insulin (RAI) analogue
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (not mixing insulins)
Number of subjects: 110
Study: 14662257

Group type: EXPERIMENTAL
Intervention: Combination of digoxin and carvedilol
Number of subjects: 47

Group type: COMPARATOR
Intervention: Digoxin alone
Number of subjects: 47

Group type: COMPARATOR
Intervention: Carvedilol alone
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Combination therapy to carvedilol alone
Number of subjects: 47

Group type: COMPARATOR
Intervention: Any therapy
Number of subjects: 47
Study: 11036893

Group type: EXPERIMENTAL
Intervention: Palliative-care intervention
Number of subjects: 434

Group type: COMPARATOR
Intervention: Conventional care (control)
Number of subjects: 434
Study: 8806342

Group type: EXPERIMENTAL
Intervention: 0.3 mg sublingual nitrate tablet
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 0.4 mg sublingual nitrate spray
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: water + 0.3 mg sublingual nitrate tablet
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: water + 0.4 mg sublingual nitrate spray
Number of subjects: 100

Group type: COMPARATOR
Intervention: control (no nitrate)
Number of subjects: 100
Study: 12319159

Group type: EXPERIMENTAL
Intervention: 15-session sex education program delivered by teachers
Number of subjects: 586
Study: 6199185

Group type: EXPERIMENTAL
Intervention: Schizophrenic children
Number of subjects: 23

Group type: COMPARATOR
Intervention: Normal children
Number of subjects: 23
Study: 31056784

Group type: EXPERIMENTAL
Intervention: Online group MBCR during chemotherapy
Number of subjects: 178

Group type: COMPARATOR
Intervention: Waitlist usual care (control)
Number of subjects: 178
Study: 29961059

Group type: EXPERIMENTAL
Intervention: Potassium chloride (40 mmol/day)
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Potassium citrate (40 mmol/day)
Number of subjects: 399

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Potassium supplementation
Number of subjects: 399
Study: 27084721

Group type: EXPERIMENTAL
Intervention: ombitasvir/paritaprevir/ritonavir 25/150/100 mg once a day for 12 weeks
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: ombitasvir/paritaprevir/ritonavir
Number of subjects: 363
Study: 24725797

Group type: EXPERIMENTAL
Intervention: Myofascial release (MFR)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham Myofascial release (SMFR)
Number of subjects: 80
Study: 22914302

Group type: EXPERIMENTAL
Intervention: Combined physiotherapy and acupuncture
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standardised exercise and advice leaflet (Control)
Number of subjects: 56
Study: 19962240

Group type: EXPERIMENTAL
Intervention: Placebo treatment
Number of subjects: 14
Study: 16988198

Group type: EXPERIMENTAL
Intervention: 2.5 mg/kg E2 and 22.5 mg/kg P per day (E2/P)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Vehicle placebo
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: E2/P
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 15481552

Group type: EXPERIMENTAL
Intervention: Training course (Group A and Group C)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Duration of education (for workers)
Number of subjects: 3

Group type: COMPARATOR
Intervention: No training course (Group B)
Number of subjects: 3
Study: 10775867

Group type: EXPERIMENTAL
Intervention: Mycophenolic acid 1% ointment
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 7
Study: 9357096

Group type: EXPERIMENTAL
Intervention: Continuous morphine drips (10‐40 micrograms/kg.h) in pediatric patients
Number of subjects: 15

Group type: COMPARATOR
Intervention: Acetaminophen with 8 mg codeine (n = 13) or 30 mg codeine (n = 5) in adult volunteers
Number of subjects: 15
Study: 7691019

Group type: EXPERIMENTAL
Intervention: Low molecular weight dextran (MW = 40,000)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Post-treatment period (20 days)
Number of subjects: 21
Study: 3779500

Group type: EXPERIMENTAL
Intervention: Cimetidine 300 mg + saline
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cimetidine 300 mg + metoclopramide 10 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ranitidine 100 mg + saline
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ranitidine 100 mg + metoclopramide 10 mg
Number of subjects: 60
Study: 31720889

Group type: EXPERIMENTAL
Intervention: TEG-guided blood product transfusion
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 58
Study: 29792372

Group type: EXPERIMENTAL
Intervention: THC:CBD oromucosal spray (Sativex®)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191
Study: 28263227

Group type: EXPERIMENTAL
Intervention: Individualized physical therapy (10 sessions targeting pathoanatomical, psychosocial, and neurophysiological factors)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Guideline-based advice (2 sessions)
Number of subjects: 300
Study: 25901479

Group type: EXPERIMENTAL
Intervention: FPNS 1 × 100 μg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: FPNS 2 × 100 μg at 4-hour intervals
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: FPNS 8 × 100 μg consecutively
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: FPNS (all regimens)
Number of subjects: 13
Study: 23719682

Group type: EXPERIMENTAL
Intervention: Hydrocodone bitartrate ER capsules
Number of subjects: 220
Study: 21818869

Group type: EXPERIMENTAL
Intervention: Cefixim
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ciprofloxacin
Number of subjects: 0
Study: 19707145

Group type: EXPERIMENTAL
Intervention: Ondansetron + Lidocaine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 30
Study: 17420366

Group type: EXPERIMENTAL
Intervention: Modified ETDRS laser photocoagulation
Number of subjects: 263

Group type: COMPARATOR
Intervention: Mild macular grid (MMG) laser technique
Number of subjects: 263
Study: 15821964

Group type: EXPERIMENTAL
Intervention: HP 3He MRI
Number of subjects: 35

Group type: COMPARATOR
Intervention: 81mKr SPECT
Number of subjects: 35
Study: 11916791

Group type: EXPERIMENTAL
Intervention: Clonidine 2.5 microg/kg
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Clonidine 5.0 microg/kg
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 107
Study: 9876334

Group type: EXPERIMENTAL
Intervention: Terbutaline (3x5 mg/day p.o.)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ketotifen (2x1 mg/day p.o. for three weeks)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8578757

Group type: EXPERIMENTAL
Intervention: Hypnosis with specific suggestions for elimination of pain
Number of subjects: 22
Study: 2244710

Group type: EXPERIMENTAL
Intervention: Nebulized atropine methylnitrate (AMN) + albuterol (ALB)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Albuterol (ALB)
Number of subjects: 8
Study: 748436

Group type: EXPERIMENTAL
Intervention: Sheltered Workshops
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Reality Orientation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Assessment‐only control
Number of subjects: 30
Study: 31129917

Group type: EXPERIMENTAL
Intervention: Pharmacy care (medication review, regular dose dispensing, and counselling)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 237
Study: 28818994

Group type: EXPERIMENTAL
Intervention: Diacerein 100 mg/day
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 25938990

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH) with vitamins and 5000 IU of dalteparin-sodium for up to 24 weeks' gestation
Number of subjects: 449

Group type: COMPARATOR
Intervention: Control group received multivitamin pills
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH)
Number of subjects: 449
Study: 24121976

Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg per day for 6 months (Group 1)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (Group 2)
Number of subjects: 46
Study: 21508756

Group type: EXPERIMENTAL
Intervention: Low-literacy Medicaid‐Title XIX Sterilization Consent Form (n=102)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Standard Medicaid‐Title XIX Sterilization Consent Form (n=99)
Number of subjects: 201
Study: 19464613

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1.0 microg/kg for 10 min, followed by 0.7 microg x kg(‐1) x hr(‐1) continuous infusion)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (ESC of fentanyl = 2 ng/mL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (ESC of fentanyl = 4 ng/mL)
Number of subjects: 30
Study: 16681478

Group type: EXPERIMENTAL
Intervention: Sildenafil (25, 50, 100 mg, as needed)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 14872172

Group type: EXPERIMENTAL
Intervention: PncDT11 vaccine
Number of subjects: 252
Study: 11566639

Group type: EXPERIMENTAL
Intervention: 20 mg PEG-OB protein/wk for 12 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 9692687

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg o.m.
Number of subjects: 169

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study: 8154486

Group type: EXPERIMENTAL
Intervention: Dietary protein intake of 1.3 g/kg body weight/d
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Dietary protein intake of 0.575 g/kg body weight/d
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Dietary protein intake of 0.28 g/kg body weight/d (supplemented with amino acids or their keto analogs)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Low-protein diets
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Baseline to follow-up change in protein intake
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Intake of fats
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Intake of cholesterol
Number of subjects: 61
Study: 2645846

Group type: EXPERIMENTAL
Intervention: Graduated compression stockings alone (group 1)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Graduated compression stockings plus intermittent pneumatic compression (IPC) (group 2)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 239
Study: 1137255

Group type: EXPERIMENTAL
Intervention: 15 mg of prednisone every 8 hours (Group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 45 mg of prednisone every morning (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 90 mg of prednisone every other morning (Group C)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Adverse reactions to prednisone (Groups A and B)
Number of subjects: 60
Study: 31184941

Group type: EXPERIMENTAL
Intervention: Computer-Controlled Local Anesthetic Delivery System (CCLADS)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Conventional intraligamentary injection
Number of subjects: 82
Study: 28200017

Group type: EXPERIMENTAL
Intervention: Tailored preventive oral health intervention
Number of subjects: 269

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 269
Study: 26317978

Group type: EXPERIMENTAL
Intervention: COBAS Amplicor V2, Roche (CA) (lower detection limit 50 IU/ml)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: VERSANT HCV-RNA Qualitative Assay, Siemens (TMA) (lower limit detection 10 IU/ml)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Both CA and TMA undetectable
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: CA undetectable/TMA positive
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: TMA undetectable patients (14 weeks treatment)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: TMA positive patients (14 weeks treatment)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Both CA and TMA undetectable (genotype 2, 14 weeks treatment)
Number of subjects: 429
Study: 22632925

Group type: EXPERIMENTAL
Intervention: Telephone motivational interviewing (MI)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Standard referral and four neutral telephone check-in sessions (control)
Number of subjects: 73
Study: 20187348

Group type: EXPERIMENTAL
Intervention: Cetirizine hydrochloride (Zyrtec, 10 mg)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 18583464

Group type: COMPARATOR
Intervention: Diet only (DO)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Diet and aerobic exercise (DA)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Diet and combined aerobic-resistance exercise (DC)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: All groups (DO, DA, DC)
Number of subjects: 94
Study: 16029782

Group type: EXPERIMENTAL
Intervention: Iridium 192 boost technique
Number of subjects: 142

Group type: COMPARATOR
Intervention: Photon/electron boost technique
Number of subjects: 142
Study: 11802244

Group type: EXPERIMENTAL
Intervention: CPX (8‐cyclopentyl‐1,3‐dipropylxanthine) at doses of 1, 3, 10, 30, 100, 300, and 1,000 mg
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: CPX (8‐cyclopentyl‐1,3‐dipropylxanthine)
Number of subjects: 37
Study: 10051781

Group type: EXPERIMENTAL
Intervention: Clinic-based intervention program emphasizing nursing involvement, physician education, provider prompts, audiovisual and printed patient education materials, transportation assistance (bus passes), preappointment reminders, and rescheduling assistance
Number of subjects: 314

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 314
Study: 7747622

Group type: EXPERIMENTAL
Intervention: Cumulative intake of aluminum gels
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis with supraphysiologic calcium concentrations
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Ingestion of calcium carbonate
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: History of diabetes mellitus
Number of subjects: 256
Study: 2245928

Group type: EXPERIMENTAL
Intervention: Diflunisal
Number of subjects: 0

Group type: COMPARATOR
Intervention: ASA (Aspirin)
Number of subjects: 0
Study: 6455734

Group type: EXPERIMENTAL
Intervention: Physical training (conditioning exercises twice a week for eight weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ergonomic counselling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 30205697

Group type: EXPERIMENTAL
Intervention: Feedback with blinded peer comparison
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 6
Study: 28992192

Group type: EXPERIMENTAL
Intervention: Blood Pressure Variability Ratio (BPVR)
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: Pulse Wave Velocity (PWV)
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: Ambulatory Arterial Stiffness Index (AASI)
Number of subjects: 772
Study: 26489804

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg and Ezetimibe 10 mg daily
Number of subjects: 1656

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1656
Study: 23128915

Group type: EXPERIMENTAL
Intervention: Transforaminal (TF) epidural steroid injection (ESI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interlaminar (IL) epidural steroid injection (ESI)
Number of subjects: 0